03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Inlyta 5mg° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Droguerie Fattal |
Distributor | Droguerie Fattal |
Laboratory | Pfizer |
Responsible Party | Pfizer Ltd |
Origin | UK |
Manufacturer | Pfizer Manufacturing Deutschland GmbH |
Origin | Germany |
ATC | L01XE17 |
Inlyta 5mg° :
Inlyta 5mg° :
Inlyta 5mg° :
Inlyta 5mg° :
Inlyta 5mg° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Inlyta 5mg° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal abscess | Not known |
Abdominal pain | Very Common |
Abdominal pain upper | Common |
Activated partial thromboplastin time prolonged | Not known |
Acute kidney injury | Not known |
Acute myocardial infarction | Not known |
Alopecia | Common |
ALT increased | Common |
Amylase increased | Common |
Anaemia | Common |
Anal abscess | Not known |
Anal fistula | Uncommon |
Anal haemorrhage | Not known |
Arterial haemorrhage | Not known |
Arthralgia (Pain joint) (Joint ache) | Very Common |
AST increased | Common |
Asthenia | Very Common |
Blood alkaline phosphatase increased | Common |
Blood creatinine increased | Common |
Blood pressure increased | Not known |
Blood thyroid stimulating hormone increased | Common |
Blood urine present | Not known |
Budd-Chiari syndrome | Not known |
Cardiac failure | Common |
Cardiopulmonary failure | Not known |
Central nervous system haemorrhage | Not known |
Cerebral haemorrhage | Not known |
Cerebrovascular accident | Not known |
Coagulation time prolonged | Not known |
Congestive heart failure | Not known |
Conjunctival haemorrhage | Not known |
Constipation | Very Common |
Contusion | Not known |
Cough | Very Common |
Decreased appetite | Very Common |
Deep vein thrombosis | Not known |
Dehydration | Common |
Diarrhoea (Diarrhea) | Very Common |
Diarrhoea haemorrhagic | Not known |
Dizziness | Common |
Dry skin | Very Common |
Dysfunctional uterine bleeding | Not known |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Very Common |
Dysphonia | Very Common |
Dyspnoea (dyspnea) | Very Common |
Ejection fraction decreased | Not known |
Embolism | Not known |
Embolism arterial | Common |
Embolism venous | Common |
Epistaxis (Nasal bleeding) | Not known |
Erythema | Common |
Fatigue | Very Common |
Fistula | Common |
Flatulence | Common |
Gastric haemorrhage | Not known |
Gastroduodenal haemorrhage | Not known |
Gastrointestinal anastomotic leak | Not known |
Gastrointestinal perforation | Common |
Gingival bleeding (Gingival hemorrhage) | Not known |
Glossodynia | Common |
Haematemesis | Not known |
Haematochezia (Hematochezia) | Not known |
Haematocrit decreased | Not known |
Haematoma | Not known |
Haematuria (Hematuria) | Not known |
Haemoglobin decreased | Not known |
Haemoptysis | Not known |
Haemorrhage | Very Common |
Haemorrhage coronary artery | Not known |
Haemorrhage urinary tract | Not known |
Haemorrhoidal haemorrhage | Not known |
Haemorrhoids | Common |
Haemostasis | Not known |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Very Common |
Headache | Very Common |
Hyperbilirubinaemia | Common |
Hypercalcaemia | Common |
Hyperkalaemia | Common |
Hypertension | Very Common |
Hypertensive crisis | Uncommon |
Hyperthyroidism | Common |
Hypothyroidism | Very Common |
Increased tendency to bruise | Not known |
INR increased | Not known |
Jugular vein thrombosis | Not known |
Large intestine perforation | Not known |
Left ventricular dysfunction | Not known |
Leucopenia (Leukopenia) | Uncommon |
Leukoencephalopathy | Not known |
Lipase increased | Common |
Lower gastrointestinal haemorrhage | Not known |
Malignant hypertension (Accelerated hypertension) | Not known |
Melaena | Not known |
Mucosal inflammation | Very Common |
Myalgia | Common |
Myocardial infarction | Not known |
Nausea | Very Common |
Neutropenia | Uncommon |
Oesophagobronchial fistula | Not known |
Oropharyngeal pain | Common |
Pain in extremity (Pain in limb) | Very Common |
Pelvic venous thrombosis | Not known |
Peritonitis | Not known |
Petechiae | Not known |
Pharyngeal haemorrhage | Not known |
Polycythaemia | Common |
Posterior reversible leukoencephalopathy syndrome (PRES) | Uncommon |
Protein urine | Not known |
Protein urine present | Not known |
Proteinuria | Very Common |
Prothrombin time prolonged | Not known |
Pruritus | Common |
Pulmonary embolism | Not known |
Pulmonary haemorrhage | Not known |
Purpura | Not known |
Rectal haemorrhage | Not known |
Red blood cell count decreased | Not known |
Renal failure | Common |
Renal haemorrhage | Not known |
Retinal artery occlusion | Not known |
Retinal vein occlusion | Not known |
Retinal vein thrombosis | Not known |
Right ventricular failure | Not known |
Scleral haemorrhage | Not known |
Scrotal haematocoele | Not known |
Skin rash | Very Common |
Splenic haematoma | Not known |
Splinter haemorrhages | Not known |
Stomatitis | Very Common |
Subarachnoid haemorrhage | Not known |
Subclavian vein thrombosis | Not known |
Thrombocytopenia (Thrombopenia) | Common |
Tinnitus | Common |
Tongue haemorrhage | Not known |
Transient ischaemic attack | Not known |
Upper gastrointestinal haemorrhage | Not known |
Vaginal haemorrhage | Not known |
Venous thrombosis | Not known |
Venous thrombosis limb | Not known |
Vomiting | Very Common |
Weight decreased (Weight loss) | Very Common |
NB : Products With Same Indication |
Different Units By MoH Code
Inlyta 5mg° MoH 7607 :
Form | Tablet, Film-Coated |
Package Size | Box of 56 |
Strength | 5mg |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✔ |
Reg. Number | 186145/13 |
Submission date | 01/01/2013 |
Registration Year | 2014 |
Withdrawn Date | 03/12/2020 |
Price Comparison
You have to register to view this info
Drop File